Recent Updates
Recently added Catalysts
ATHE Negative Sentiment Score: 30/100

Notification of cessation of +securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Thursday

Key Takeaway: Alterity Therapeutics Limited has announced the cessation of 674,694,939 ordinary securities (ATHAAC) due to their expiry without exercise or conversion on November 23, 2023. This cessation means the options will no longer be available, potentially impacting the company’s capital structure. Following this expiry, the company will continue to maintain a diverse portfolio of other options and ordinary shares.

Market Sentiment Analysis

CONCERNS & RISKS

  • Cessation of a significant number of securities (674,694,939 options) due to expiry without conversion.
  • The announcement indicates a potential decrease in available capital, affecting investor confidence.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Thursday November 30, 2023
Details of +securities that have ceased
ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation
ATHAAC ORDINARY FULLY 23-NOV-2023 EX $0.07 674,694,939 Expiry of option or other convertible security without exercise or conversion 23/11/2023
Refer to next page for full
details of the announcement
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information
about our issued capital.
1.2 Registered number type Registration number
ABN 37080699065
Date of this announcement
ASX +Security Code and Description
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07
Unquoted +equity securities that have ceased
Number of securities that have
Reason for cessation
Expiry of option or other convertible security without exercise
Date of cessation Is the entity paying any consideration for the cessation?
23/11/2023 No
other information the entity wishes to notify to ASX about the cessation?
Following the cessation
of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities
(total number of each +class of +securities quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,802,360,380
Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 0
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
Note: the figures stated in the tables above are used
to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes
of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the
entity has advised ASX of a change to that class of +security in Part 2 of this form.

Frequently Asked Questions

What securities ceased for Alterity Therapeutics?

The ATHAAC options expired without exercise on November 23, 2023.

How many ATHAAC securities have ceased?

674,694,939 ATHAAC securities have ceased due to expiry.

What is the reason for the cessation of these securities?

The cessation occurred due to the expiry of options without exercise.

Are there any considerations paid for the ceased securities?

No consideration is being paid for the cessation of these securities.

What is the status of Alterity's issued capital post-cessation?

Post-cessation, the issued capital includes 2,802,360,380 ordinary fully paid securities.

Last updated: Nov 30, 2023